John Oyler, CEO and Co-Founder of BeiGene, talks about BeiGene’s long-term partnership with Hillhouse and how this partnership has helped the company achieve its goals.

BeiGene is a global biotechnology company focused on delivering world-class innovative therapies at affordable prices for patients worldwide.